Type I interferon antagonism of the JMJD3-IRF4 pathway modulates macrophage activation and polarization
Open Access
- 19 April 2022
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 39 (3) , 110719
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council (1159901)
- University of Melbourne
- CSL Ltd
This publication has 35 references indexed in Scilit:
- Metabolic reprogramming in macrophages and dendritic cells in innate immunityCell Research, 2015
- Application of dynamic metabolomics to examine in vivo skeletal muscle glucose metabolism in the chronically high-fat fed mouseBiochemical and Biophysical Research Communications, 2015
- Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage PolarizationImmunity, 2015
- Intracellular α-ketoglutarate maintains the pluripotency of embryonic stem cellsNature, 2014
- Succinate is an inflammatory signal that induces IL-1β through HIF-1αNature, 2013
- A selective jumonji H3K27 demethylase inhibitor modulates the proinflammatory macrophage responseNature, 2012
- The mitochondrial citrate carrier: a new player in inflammationBiochemical Journal, 2011
- The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infectionNature Immunology, 2010
- The IRF Family Transcription Factors in Immunity and OncogenesisAnnual Review of Immunology, 2008
- Histone Lysine Demethylases and Their Impact on EpigeneticsCell, 2006